Table 3: Mean ± SEM Levels of IFN-γ (μg mL-1) in supernatant of PBMC culture from HIV-1 positive blood donors stimulated with mitogen (PHA), M.tb specific antigen (PPD) and BCG with or without supplementation of recombinant IL-12 (rIL-12).
Stimulus |
Replacement (n = 70) |
Voluntary (n = 74) |
Control (n = 100) |
||
First TST |
Second TST |
First TST |
Second TST |
||
PHA |
9.6 ± 6.4 |
10.4 ± 4.6 |
12.4 ± 6.6 |
11.6 ± 6.2 |
11.2 ± 4.8 |
PPD |
0.9 ± 0.22* |
4.6 ± 2.6 |
5.6 ± 3.2 |
5.8 ± 4.4 |
5.2 ± 2.4 |
PPD + rIL-12 |
7.4 ± 2.4** |
5.6 ± 2.8 |
6.1 ± 3.6 |
5.7 ± 2.9 |
6.2 ± 1.8 |
BCG |
8.4 ± 5.10 |
12.3 ± 4.7 |
11.6 ± 6.4 |
12.8 ± 7.2 |
10 ± 7.4 |
BCG + rIL-12 |
10.6 ± 2.3 |
14.6 ± 6.8 |
22 ± 9.6 |
8.9 ± 3.2 |
11.5 ± 3 |
*Significant depression (p < 0.001) compared to controls; **Significant elevation (p < 0.001) by rIL-12 pre-treatment of PBMC in PPD stimulated PBMC culture compared to untreated PPD stimulated PBMC culture.